Healthy Skepticism Library Topics: Evaluation of Evidence

Evaluation of Evidence

This page lists 34 references in the Main Healthy Skepticism Library relevant to evaluation of evidence including evidence based medicine and evidence based practice.

Click on the HSL (Health Skepticism Library) number for more details which may include an abstract or full text.

HSL6322
Bramwell R, West H, Salmon P.
Health professionals' and service users' interpretation of screening test results: experimental study
BMJ 2006 Aug 5;333(7562):284
http://bmj.bmjjournals.com/cgi/content/short/333/7562/284?etoc%3e

HSL6847
Shulman LP, Bateman LH, Creinin MD, Cullins VE, Doyle LL, Godfrey E, Murphy P, Rodriguez P, Spear SJ, Stewart FH, Thomas MA, Westhoff CL, Worthington S.
Surrogate markers, emboldened and boxed warnings, and an expanding culture of misinformation: evidence-based clinical science should guide FDA decision making about product labeling.
Contraception 2006 May 01;73(5):440-2
http://linkinghub.elsevier.com/retrieve/pii/S0010-7824(06)00034-5

HSL6546
Ivanitskaya L, O'Boyle I, Casey AM.
Health information literacy and competencies of information age students: results from the interactive online Research Readiness Self-Assessment (RRSA).
J Med Internet Res 2006 Apr 21;8(2):e6
http://www.jmir.org/2006/2/e6/

HSL5706
Davis RL, Khoury MJ.
A public health approach to pharmacogenomics and gene-based diagnostic tests.
Pharmacogenomics 2006 Apr 01;7(3):331-7
http://www.futuremedicine.com/doi/abs/10.2217/14622416.7.3.331

HSL5756
Oaks D.
Why did the FDA approve these advertisements?
PLoS Med 2006 Feb 01;3(2):e117
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0030117

HSL5422
Montori VM, Leung TW, Devereaux PJ, Schunemann HJ, Akl EA, Gafni A, Guyatt GH.
Can contraindications compromise evidence-based, patient-centered clinical practice?
Can J Clin Pharmacol 2006 Win;13(1):e92-101

HSL5066
Wright J.
Hormone replacement therapy: an example of McKinlay's theory on the seven stages of medical innovation.
J Clin Nurs 2005 Oct;14(9):1090-7

HSL2833
Miller DW, Miller CG.
On Evidence, Medical and Legal.
Journal of American Physicians and Surgeons 2005 Fall;10(3):70-75
http://www.jpands.org/vol10no3/miller.pdf

HSL1907
Words to the wise healthcare consumer: Approach with caution
2005 Jun 8

HSL5983
Campo K, De Staebel O, Gijsbrechts E, van Waterschoot W.
Physicians' decision process for drug prescription and the impact of pharmaceutical marketing mix instruments.
Health Mark Q 2005;22(4):73-107

HSL2091
Andrews E, Dombeck M.
The role of scientific evidence of risks and benefits in determining risk management policies for medications.
Pharmacoepidemiol Drug Saf 2004 Sep;13(9):599-608
http://www3.interscience.wiley.com/cgi-bin/abstract/105560406/ABSTRACT

HSL5847
Sweet M.
Development of strategies to encourage adoption of best evidence into practice in Australia: workshop overview.
Med J Aust 2004 Mar 15;180(6)
http://www.mja.com.au/public/issues/180_06_150304/swe10882_fm.html

HSL5845
Sanson-Fisher RW, Grimshaw JM, Eccles MP.
The science of changing providers' behaviour: the missing link in evidence-based practice.
Med J Aust 2004 Mar 1;180(5):205-6
http://www.mja.com.au/public/issues/180_05_010304/san10013_fm.html

HSL2444
Young JM, Glasziou P, Ward JE.
General practitioners' self ratings of skills in evidence based medicine: validation study.
BMJ 2002 Apr 20;324(7343):950-1
http://bmj.bmjjournals.com/cgi/content/full/324/7343/950

HSL2458
Shakir SA, Layton D.
Causal association in pharmacovigilance and pharmacoepidemiology: thoughts on the application of the Austin Bradford-Hill criteria.
Drug Saf 2002;25(6):467-71
Nil

HSL4161
Innvaer S, Vist G, Trommald M, Oxman A.
Health policy-makers’ perceptions of their use of evidence: a systematic review.
J Health Ser Res Policy. 2002;4:239–244

HSL2455
Kluger AN, Tikochinsky J.
The error of accepting the "theoretical" null hypothesis: the rise, fall, and resurrection of commonsense hypotheses in psychology.
Psychol Bull 2001 May;127(3):408-23
http://content.apa.org/journals/bul/127/3/408

HSL2159
Slawson DC, Shaughnessy AF.
Teaching information mastery: creating informed consumers of medical information.
J Am Board Fam Pract 1999 Nov-Dec;12(6):444-9

HSL2456
Bucher HC, Guyatt GH, Cook DJ, Holbrook A, McAlister FA.
Users' guides to the medical literature: XIX .Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points. Evidence-Based Medicine Working Group.
JAMA 1999 Aug 25;282(8):771-8
http://jama.ama-assn.org/cgi/content/full/282/8/771

HSL2140
Razack S, Arbour L, Hutcheon R.
Proposed model for interaction between residents and residency training programs, and pharmaceutical industry.
Ann R Coll Physicians Surg Can 1999 Mar;32(2):93-6

HSL2443
McColl A, Smith H, White P, Field J.
General practitioner's perceptions of the route to evidence based medicine: a questionnaire survey.
BMJ 1998 Jan 31;316(7128):361-5
http://bmj.bmjjournals.com/cgi/content/full/316/7128/361

HSL2457
Fleming TR, DeMets DL.
Surrogate end points in clinical trials: are we being misled?
Ann Intern Med 1996 Oct 1;125(7):605-13
http://www.annals.org/cgi/content/full/125/7/605

HSL5891
Naylor CD.
Grey zones of clinical practice: some limits to evidence-based medicine.
Lancet 1995 Apr 1;345(8953):840-2

HSL4661
Goldstein JH.
Doctoring medicine: reading between the lines of drug advertisements
Journal of Medical Humanities 1991;12(2):73-83

HSL4663
Harvey K, Mansfield P.
Drug promotion: the critical approach
Australian Prescriber 1991;14(1):34-35

HSL4682
Mansfield PR.
Classifying improvements to drug marketing and justifications for claims of efficacy
International Journal of Risk & Safety in Medicine 1991;2:171-184

HSL4605
Williams EB.
Advertising acyclovir
Lancet 1990;335:288

HSL3920
Stross JK.
Information sources and clinical decisions.
J Gen Intern Med 1987 May-Jun;2(3):155-9

HSL3958
Re: the promotion of loperamide
1987 Feb

HSL3712
Dasco CC.
A physician/medical industrial ethos
American Journal of Medicine 1985;79:675

HSL3648
Parboosingh J, Lockyer J, McDougall G, Chugh U.
How physicians make changes in their clinical practice: a study of physicians’ perception of factors that facilitate this process
Annals of the Royal College of Physicians and Surgeons of Canada 1984;17:429-435

HSL3498
Christensen DB, Bush PJ.
Drug prescribing: patterns, problems and proposals.
Soc Sci Med [A] 1981 May;15(3)

HSL3281
Williamson PM.
How general practitioners assess risks in using new drugs.
J R Coll Gen Pract 1975 May;25(154):383-6

HSL2938
Greenblatt DJ, Shader RI.
Meprobamate: a study of irrational drug use.
Am J Psychiatry 1971 Apr;127(10):1297-303

		Healthy Skepticism Countering misleading drug promotion Home \| About us \| Site info \| Contact us \| Links \| Other What's new \| AdWatch \| HS Int News \| Library \| Fora
Home - www.healthyskepticism.org > library > topics: evaluation : Updated 22 August, 2005
For you Free Updates Can we help you? Help the cause Join in Subscribe to Healthy Skepticism Updates Feedback If you like our work please tell others. If not, please tell us.		Evaluation of Evidence This page lists 34 references in the Main Healthy Skepticism Library relevant to evaluation of evidence including evidence based medicine and evidence based practice. Click on the HSL (Health Skepticism Library) number for more details which may include an abstract or full text. HSL6322 Bramwell R, West H, Salmon P. Health professionals' and service users' interpretation of screening test results: experimental study BMJ 2006 Aug 5;333(7562):284 http://bmj.bmjjournals.com/cgi/content/short/333/7562/284?etoc%3e HSL6847 Shulman LP, Bateman LH, Creinin MD, Cullins VE, Doyle LL, Godfrey E, Murphy P, Rodriguez P, Spear SJ, Stewart FH, Thomas MA, Westhoff CL, Worthington S. Surrogate markers, emboldened and boxed warnings, and an expanding culture of misinformation: evidence-based clinical science should guide FDA decision making about product labeling. Contraception 2006 May 01;73(5):440-2 http://linkinghub.elsevier.com/retrieve/pii/S0010-7824(06)00034-5 HSL6546 Ivanitskaya L, O'Boyle I, Casey AM. Health information literacy and competencies of information age students: results from the interactive online Research Readiness Self-Assessment (RRSA). J Med Internet Res 2006 Apr 21;8(2):e6 http://www.jmir.org/2006/2/e6/ HSL5706 Davis RL, Khoury MJ. A public health approach to pharmacogenomics and gene-based diagnostic tests. Pharmacogenomics 2006 Apr 01;7(3):331-7 http://www.futuremedicine.com/doi/abs/10.2217/14622416.7.3.331 HSL5756 Oaks D. Why did the FDA approve these advertisements? PLoS Med 2006 Feb 01;3(2):e117 http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0030117 HSL5422 Montori VM, Leung TW, Devereaux PJ, Schunemann HJ, Akl EA, Gafni A, Guyatt GH. Can contraindications compromise evidence-based, patient-centered clinical practice? Can J Clin Pharmacol 2006 Win;13(1):e92-101 HSL5066 Wright J. Hormone replacement therapy: an example of McKinlay's theory on the seven stages of medical innovation. J Clin Nurs 2005 Oct;14(9):1090-7 HSL2833 Miller DW, Miller CG. On Evidence, Medical and Legal. Journal of American Physicians and Surgeons 2005 Fall;10(3):70-75 http://www.jpands.org/vol10no3/miller.pdf HSL1907 Words to the wise healthcare consumer: Approach with caution 2005 Jun 8 HSL5983 Campo K, De Staebel O, Gijsbrechts E, van Waterschoot W. Physicians' decision process for drug prescription and the impact of pharmaceutical marketing mix instruments. Health Mark Q 2005;22(4):73-107 HSL2091 Andrews E, Dombeck M. The role of scientific evidence of risks and benefits in determining risk management policies for medications. Pharmacoepidemiol Drug Saf 2004 Sep;13(9):599-608 http://www3.interscience.wiley.com/cgi-bin/abstract/105560406/ABSTRACT HSL5847 Sweet M. Development of strategies to encourage adoption of best evidence into practice in Australia: workshop overview. Med J Aust 2004 Mar 15;180(6) http://www.mja.com.au/public/issues/180_06_150304/swe10882_fm.html HSL5845 Sanson-Fisher RW, Grimshaw JM, Eccles MP. The science of changing providers' behaviour: the missing link in evidence-based practice. Med J Aust 2004 Mar 1;180(5):205-6 http://www.mja.com.au/public/issues/180_05_010304/san10013_fm.html HSL2444 Young JM, Glasziou P, Ward JE. General practitioners' self ratings of skills in evidence based medicine: validation study. BMJ 2002 Apr 20;324(7343):950-1 http://bmj.bmjjournals.com/cgi/content/full/324/7343/950 HSL2458 Shakir SA, Layton D. Causal association in pharmacovigilance and pharmacoepidemiology: thoughts on the application of the Austin Bradford-Hill criteria. Drug Saf 2002;25(6):467-71 Nil HSL4161 Innvaer S, Vist G, Trommald M, Oxman A. Health policy-makers’ perceptions of their use of evidence: a systematic review. J Health Ser Res Policy. 2002;4:239–244 HSL2455 Kluger AN, Tikochinsky J. The error of accepting the "theoretical" null hypothesis: the rise, fall, and resurrection of commonsense hypotheses in psychology. Psychol Bull 2001 May;127(3):408-23 http://content.apa.org/journals/bul/127/3/408 HSL2159 Slawson DC, Shaughnessy AF. Teaching information mastery: creating informed consumers of medical information. J Am Board Fam Pract 1999 Nov-Dec;12(6):444-9 HSL2456 Bucher HC, Guyatt GH, Cook DJ, Holbrook A, McAlister FA. Users' guides to the medical literature: XIX .Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points. Evidence-Based Medicine Working Group. JAMA 1999 Aug 25;282(8):771-8 http://jama.ama-assn.org/cgi/content/full/282/8/771 HSL2140 Razack S, Arbour L, Hutcheon R. Proposed model for interaction between residents and residency training programs, and pharmaceutical industry. Ann R Coll Physicians Surg Can 1999 Mar;32(2):93-6 HSL2443 McColl A, Smith H, White P, Field J. General practitioner's perceptions of the route to evidence based medicine: a questionnaire survey. BMJ 1998 Jan 31;316(7128):361-5 http://bmj.bmjjournals.com/cgi/content/full/316/7128/361 HSL2457 Fleming TR, DeMets DL. Surrogate end points in clinical trials: are we being misled? Ann Intern Med 1996 Oct 1;125(7):605-13 http://www.annals.org/cgi/content/full/125/7/605 HSL5891 Naylor CD. Grey zones of clinical practice: some limits to evidence-based medicine. Lancet 1995 Apr 1;345(8953):840-2 HSL4661 Goldstein JH. Doctoring medicine: reading between the lines of drug advertisements Journal of Medical Humanities 1991;12(2):73-83 HSL4663 Harvey K, Mansfield P. Drug promotion: the critical approach Australian Prescriber 1991;14(1):34-35 HSL4682 Mansfield PR. Classifying improvements to drug marketing and justifications for claims of efficacy International Journal of Risk & Safety in Medicine 1991;2:171-184 HSL4605 Williams EB. Advertising acyclovir Lancet 1990;335:288 HSL3920 Stross JK. Information sources and clinical decisions. J Gen Intern Med 1987 May-Jun;2(3):155-9 HSL3958 Re: the promotion of loperamide 1987 Feb HSL3712 Dasco CC. A physician/medical industrial ethos American Journal of Medicine 1985;79:675 HSL3648 Parboosingh J, Lockyer J, McDougall G, Chugh U. How physicians make changes in their clinical practice: a study of physicians’ perception of factors that facilitate this process Annals of the Royal College of Physicians and Surgeons of Canada 1984;17:429-435 HSL3498 Christensen DB, Bush PJ. Drug prescribing: patterns, problems and proposals. Soc Sci Med [A] 1981 May;15(3) HSL3281 Williamson PM. How general practitioners assess risks in using new drugs. J R Coll Gen Pract 1975 May;25(154):383-6 HSL2938 Greenblatt DJ, Shader RI. Meprobamate: a study of irrational drug use. Am J Psychiatry 1971 Apr;127(10):1297-303
818 visits to this page since 1 January 2007		Home \| Add to Favourites \| Site Map \| Credits \| Privacy Policy \| Update Policy \| Feedback Policy

Countering misleading drug promotion

Evaluation of Evidence